Bloomberg News

Shanghai Pharma Seeks ‘Sizeable M&A’ Deals, Credit Suisse Says

October 03, 2011

Oct. 4 (Bloomberg) -- Shanghai Pharmaceuticals Holding Co., China’s third-largest drugmaker, is actively looking for “sizeable” merger and acquisition opportunities to strengthen its product portfolio and market presence, Credit Suisse said.

According to management, any strategic M&A with a pharma company could be a positive catalyst, Credit Suisse Hong Kong- based analysts Lefei Sun and Jinsong Du said in a report today in which they reiterated an “outperform” rating on the shares.

To contact the editor responsible for this story: Jason Gale at

We Almost Lost the Nasdaq

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus